Standard BioTools Net Profit Margin 2010-2023 | LAB
Standard BioTools net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Standard BioTools Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-12-31 | $0.11B | $-0.08B | -70.75% |
| 2023-09-30 | $0.11B | $-0.08B | -72.38% |
| 2023-06-30 | $0.11B | $-0.08B | -79.25% |
| 2023-03-31 | $0.10B | $-0.13B | -135.05% |
| 2022-12-31 | $0.10B | $-0.19B | -191.92% |
| 2022-09-30 | $0.11B | $-0.18B | -161.82% |
| 2022-06-30 | $0.11B | $-0.16B | -144.25% |
| 2022-03-31 | $0.13B | $-0.12B | -92.80% |
| 2021-12-31 | $0.13B | $-0.06B | -45.04% |
| 2021-09-30 | $0.14B | $-0.07B | -49.28% |
| 2021-06-30 | $0.15B | $-0.06B | -40.27% |
| 2021-03-31 | $0.14B | $-0.06B | -38.89% |
| 2020-12-31 | $0.14B | $-0.05B | -38.13% |
| 2020-09-30 | $0.13B | $-0.05B | -38.10% |
| 2020-06-30 | $0.11B | $-0.06B | -49.11% |
| 2020-03-31 | $0.11B | $-0.06B | -49.12% |
| 2019-12-31 | $0.12B | $-0.07B | -56.03% |
| 2019-09-30 | $0.12B | $-0.07B | -57.76% |
| 2019-06-30 | $0.12B | $-0.07B | -57.98% |
| 2019-03-31 | $0.12B | $-0.07B | -60.68% |
| 2018-12-31 | $0.11B | $-0.06B | -52.68% |
| 2018-09-30 | $0.11B | $-0.05B | -50.00% |
| 2018-06-30 | $0.10B | $-0.06B | -52.88% |
| 2018-03-31 | $0.10B | $-0.06B | -54.90% |
| 2017-12-31 | $0.10B | $-0.06B | -58.25% |
| 2017-09-30 | $0.10B | $-0.07B | -68.00% |
| 2017-06-30 | $0.10B | $-0.07B | -74.23% |
| 2017-03-31 | $0.10B | $-0.07B | -73.27% |
| 2016-12-31 | $0.10B | $-0.08B | -74.04% |
| 2016-09-30 | $0.11B | $-0.07B | -65.45% |
| 2016-06-30 | $0.12B | $-0.06B | -52.14% |
| 2016-03-31 | $0.12B | $-0.06B | -48.31% |
| 2015-12-31 | $0.12B | $-0.05B | -45.69% |
| 2015-09-30 | $0.12B | $-0.05B | -43.22% |
| 2015-06-30 | $0.12B | $-0.06B | -47.06% |
| 2015-03-31 | $0.12B | $-0.05B | -45.76% |
| 2014-12-31 | $0.12B | $-0.05B | -45.30% |
| 2014-09-30 | $0.11B | $-0.05B | -44.76% |
| 2014-06-30 | $0.09B | $-0.04B | -39.78% |
| 2014-03-31 | $0.08B | $-0.03B | -34.15% |
| 2013-12-31 | $0.07B | $-0.02B | -23.94% |
| 2013-09-30 | $0.07B | $-0.02B | -24.24% |
| 2013-06-30 | $0.06B | $-0.02B | -26.23% |
| 2013-03-31 | $0.06B | $-0.02B | -29.82% |
| 2012-12-31 | $0.05B | $-0.02B | -37.74% |
| 2012-09-30 | $0.05B | $-0.02B | -38.00% |
| 2012-06-30 | $0.05B | $-0.02B | -39.58% |
| 2012-03-31 | $0.05B | $-0.02B | -45.65% |
| 2011-12-31 | $0.04B | $-0.03B | -70.45% |
| 2011-09-30 | $0.04B | $-0.03B | -75.61% |
| 2011-06-30 | $0.04B | $-0.03B | -78.95% |
| 2011-03-31 | $0.04B | $-0.03B | -80.00% |
| 2010-12-31 | $0.03B | $-0.02B | -51.52% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.719B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $34.790B | 19.11 |
| Inspire Medical Systems (INSP) | United States | $7.322B | 0.00 |
| 10x Genomics (TXG) | United States | $3.489B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.410B | 0.00 |
| Axonics (AXNX) | United States | $3.396B | 0.00 |
| Enovis (ENOV) | United States | $3.029B | 23.01 |
| Azenta (AZTA) | United States | $2.925B | 238.46 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.864B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.685B | 0.00 |
| Privia Health (PRVA) | United States | $2.183B | 96.84 |
| Schrodinger (SDGR) | United States | $1.763B | 0.00 |
| Omnicell (OMCL) | United States | $1.231B | 30.12 |
| Phreesia (PHR) | United States | $1.169B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.817B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.783B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.608B | 0.00 |
| Talkspace (TALK) | United States | $0.519B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.367B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.333B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
| Pulmonx (LUNG) | United States | $0.293B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.170B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.148B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.139B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| Outset Medical (OM) | United States | $0.131B | 0.00 |
| TruBridge (TBRG) | United States | $0.116B | 4.94 |
| 111 (YI) | China | $0.087B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
| Movano (MOVE) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |